Rare Diseases South Africa: A Beacon of Hope
A Personal Journey to Advocacy
Rare Diseases South Africa (RDSA) was founded in 2013 by Kelly du Plessis, driven by a deeply personal journey. When Kelly's son was diagnosed with a rare disease, she encountered the stark reality of limited awareness and support for rare diseases in South Africa. This personal experience ignited a passion to create change, leading to the establishment of RDSA, a non-profit organization dedicated to advocating for individuals living with rare diseases and congenital disorders.
Championing Rare Diseases
RDSA's mission is to ensure that people living with rare diseases and congenital disorders receive the recognition, support, and health services they deserve. The organization works tirelessly to influence policy, raise awareness, and provide resources to patients and their families. By engaging with governmental departments, industry players, and strategic stakeholders, RDSA aims to move rare disease policy forward and improve the quality of life for those affected.
Empowering Through Craft: The Rare Bear Project
One of RDSA's standout initiatives is the Rare Bear Project. This community upliftment program empowers women through crafts, providing them with income-generating opportunities. The project involves handcrafting sustainable, unique gifts for children and rare disease patients. Each Rare Bear is made with love and care, symbolizing the support and solidarity of the rare disease community.
For more information about the Rare Bear Project, visit https://www.rarebearproject.org/.
A Multifaceted Approach
RDSA's efforts are multifaceted, focusing on several key areas:
Advocacy: Working to influence policy and ensure that rare disease patients receive the necessary support and treatment.
Awareness: Educating the public and healthcare professionals about rare diseases to improve early diagnosis and treatment.
Support: Providing resources and support to patients and their families to help them navigate the challenges of living with a rare disease.
Research: Promoting and supporting research initiatives to better understand rare diseases and develop effective treatments.
If you want to know more, visit our website at https://www.rarediseases.co.za/.
By spotlighting Rare Diseases South Africa, we hope to raise awareness and support for the vital work they do in advocating for and supporting individuals living with rare diseases in South Africa.
Get in Touch
For more information or to get involved with Rare Diseases South Africa, you can reach out to them through the following channels:
Telephone: +27 10 594 3844
Hotline: 072 476 7552
Email: hello@rarediseases.co.za
More About the Founder
Kelly du Plessis
Kelly du Plessis is the Founder and CEO of Rare Diseases South Africa (RDSA). Kelly is deeply passionate about advocating for rare disease patients, driven by personal experience as a mother to a rare warrior.
In her role at RDSA, Kelly is responsible for ensuring that no rare patient is left behind in the complex healthcare system. She focuses on advocating for policy changes and driving initiatives that support rare disease patients. Kelly's responsibilities also include leading the organization through the challenges of operating as a non-profit, ensuring the sustainability of their initiatives, and fostering a collaborative and supportive environment for her team.
Kelly describes herself as a "Jack of all trades and master of none," highlighting her hands-on approach to leadership. She is ultimately responsible for keeping the organization afloat, steering it in the right direction, and ensuring that the team has the necessary resources to succeed. Her strengths lie in her passion for people, her determination to get things done, and her pragmatic approach to advocacy.
Kelly's top activities as CEO include being the voice of the organization, leading change, and engaging with various stakeholders to drive collaboration. She faces barriers such as maintaining focus, managing time effectively, and dealing with resource constraints.
Overall, Kelly du Plessis is a dedicated and passionate leader, committed to making a significant impact in the lives of rare disease patients and their families.
Latest from Know Rare
From prenatal uncertainty and postpartum anxiety to therapy, grief, and hope, a mother shares her experience raising a child with a rare disease, navigating the healthcare system, finding community, and learning to embrace a different—but deeply meaningful—path as a parent.
A Danon disease study, led by researcher Dr. Barry Greenberg and published in the New England Journal of Medicine, wins an award! The study focuses on gene therapy as a potential treatment option for Danon disease. The study showed early signs that gene therapy may help the hearts of people with Danon disease.
A poster, presented at the European Hematology Association meeting in June, described a study that looked at tiredness (fatigue) in adults with immune thrombocytopenia (ITP). Researchers wanted to see if fatigue was related to bleeding or other health test results.
Lucky Shanmugan was recently featured in Porter Ranch Living, his local magazine, for Father’s Day: in his interview, Lucky talks about Osteogenesis Imperfecta, a rare genetic or heritable disorder of the connective tissue, and the incredible journey towards his official diagnosis.
Here are 9 things Chris Anselmo wishes someone had told him after his rare disease diagnosis.
A family’s hardships and resilience in finding answers and getting a diagnosis for their child, after numerous tests, brain biopsies, and hospitalizations. And the relief but also grief in finally putting a name to the rare disease that affects their child: BCL11B-related disorder.
The Danon Foundation boldly empowers people living with Danon disease, providing trusted information, resources and support to help navigate life, from diagnosis to treatment.
For many families, caregiving for a child with a rare or medically complex condition is a full-time job. The problem is, it’s a job with no training, no time off, and no clear job description. If you’re looking for the light at the end of the tunnel, you don’t have to search alone. Check out some of Paige’s favorite resources.
For most of celiacs, despite months on a strict GF diet, energy stays low and blood work reveals nutrient deficiencies. The lesson? A "gluten-free" label isn't a health guarantee—just a guarantee you'll pay more.
If you’ve been told you have seronegative NMOSD, there’s nearly 50/50 chance you have a different antibody causing your symptoms –MOG antibody.
Therapy Near Me is a nationwide mental health service based in Australia, providing easy access to psychologists, counsellors, behaviour support practitioners and social workers.
At the annual Kidney Week of the American Society of Nephrologists (ASN), the world’s largest kidney healthcare professional organization, new advances in research were highlighted. Over $35 million has been invested in research with the ASN, and there are many treatments in development for IgA Nephropathy (IgAN), with researchers actively investigating more than 20 different drugs.
When I was diagnosed with celiac disease, I thought avoiding bread and pasta would be enough. I quickly learned that living truly gluten-free is far more complex, and I'm sharing my experience to help newly diagnosed individuals understand what lies ahead.
Retinopathy is an eye problem that many people with Danon disease have. It can cause dark spots in the outer part of the eye, blurry or worse vision, and unusual test results on an eye exam. Sometimes these eye changes show up before heart problems, so an eye check can help find the disease early.
A heartfelt story about a mother who found purpose and strength among the tragedy of losing a child diagnosed with an ultra rare genetic disorder.
Kaya Girl Legacy, Inc. is a Florida-based nonprofit founded in memory of Kaya Humbert, a beautiful baby girl born with Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS), one of 46 known cases worldwide. The foundation is dedicated to empowering families with knowledge about their genetic health and advocating for early access to genetic testing and rare disease awareness.
A prose poem by Jim Kuhn, a rare warrior living with Sarcoidosis, a rare inflammatory disease.
Rare Mom Laura shares how her family’s prep for Halloween turned into a burst of familial love and creativity, as they all worked together in designing and building a costume for Alden, her medically complex son.
Instead of starting with a newly discovered drug compound, PCOR is a type of research that starts by turning to patients and caregivers and asking, What matters most to you? What questions do we want answered? What symptoms do we wish were better managed? What keeps us up at night?
Four years ago, Michael Grivas’ life suddenly changed when he learned that he had Brugada Syndrome, a genetic disorder in which the electrical activity of the heart is abnormal due to channelopathy. Learn more about his story.
Fatigue is a very common and often debilitating symptom of IgAN. It is linked to disease progression and reduced kidney function, but other factors like inflammation, anemia, and mental health also play a role. In a 2025 study, the majority of patients with IgAN reported fatigue, and patients with more severe proteinuria and lower kidney filtration rates (eGFR) experienced worse fatigue.
Why is it so hard to accept help? Humans often associate help with weakness and loss of independence and control. However, if we reframe our thoughts, accepting help can be viewed as a form of empowerment: showing vulnerability and trusting someone to help us requires great strength.
There is so much mental load with having a rare disease. Rare Human Lindsay shares there are things she does not care about anymore, as she manages rare disease symptoms, specialists, and clinical trials.
Rare Human Lindsay shares her "silver linings." It's not 'what doesn't kill you makes you stronger,' instead it's what doesn't kill you makes you braver. She shares that she has found deeper connections with others, improved her ability to ask for and accept help, and not been as afraid of the word "no."
Journalist and rare disease advocate Lindsay Guentzel breaks down why clinical trials are a lifeline for the rare disease community. With only 5% of known rare diseases having an FDA-approved therapy, trials often represent the only path toward treatment, progress, and hope.
Lindsay was diagnosed with dermatomyositis a couple of years ago. Since then, she has undergone more than 350 doctor appointments, 250+ hours of infusions, 10+ ER visits, while juggling insurance approvals, rides, and her pain and fatigue.
Rare Human Lindsay is in the midst of her first clinical trial for dermatomyositis, a rare inflammatory disease that primarily affects the skin and muscles. So far, she has learned so much about the process and is eager to share some of her insights with the rare disease community.